Literature DB >> 10862044

Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome.

I I Wistuba1, G E Tomlinson, C Behrens, A Virmani, J Geradts, J L Blum, J D Minna, A F Gazdar.   

Abstract

Monozygotic twins, each of whom has breast cancer, offer a natural study population for gene-environmental interactions as causation of cancer, because they are genetically identical. If heritable factors play a large role in the origin of a neoplasm, disease concordance should be significant in monozygotic twins. Two monozygotic triplet sisters carrying a germline BRCA1 gene mutation (5382insC) who both developed breast cancer at early ages were studied for loss of heterozygosity (LOH) in their microdissected, paraffin-embedded tumors along with control blood and stromal breast tissue at 19 chromosomal arms using 161 microsatellite markers. Microdissected areas of normal lobular and ductal epithelium and ductal in situ carcinoma were also studied for LOH using a subset of microsatellite markers. The mother's DNA (extracted from peripheral blood lymphocytes) was analyzed to determine the parental allele under LOH in each case. Both tumors demonstrated similar histologic features suggestive of a secretory variant of ductal carcinoma. The tumors from both sisters had similar overall LOH frequency expressed by the fractional allelic loss (FAL) indices (0.56 vs. 0.60) and demonstrated concordance for loss or retention at 82 of 97 informative markers (85% correlation). In addition, detailed mapping analysis of several chromosomal arms revealed that identical breakpoints were detected in both tumors at several chromosome regions. Finally, in both sisters' tumors, when a chromosome exhibited allelic loss, all of the markers exhibited LOH of the same parental allele even when there were intervening regions of retention of heterozygosity. In contrast, 17 archival sporadic breast carcinomas demonstrated a wide range of FAL indexes and highly individual patterns of LOH. Our findings support the hypothesis that inherited factors play a role in the development of the multiple somatic deletions occurring in breast carcinomas. Whether one of these factors is the mutant BRCA1 allele or some other gene(s) remains to be determined. Genes Chromosomes Cancer 28:359-369, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862044     DOI: 10.1002/1098-2264(200008)28:4<359::aid-gcc1>3.0.co;2-n

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  History of the Baylor Charles A. Sammons Cancer Center.

Authors:  Marvin J Stone; Billie E Aronoff; W Phil Evans; Joseph W Fay; Z H Lieberman; Carolyn M Matthews; George J Race; R Pickett Scruggs; C Allen Stringer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

2.  High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.

Authors:  A Maitra; I I Wistuba; C Washington; A K Virmani; R Ashfaq; S Milchgrub; A F Gazdar; J D Minna
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Contralateral breast cancers: Independent cancers or metastases?

Authors:  Colin B Begg; Irina Ostrovnaya; Felipe C Geyer; Anastasios D Papanastasiou; Charlotte K Y Ng; Rita A Sakr; Jonine L Bernstein; Kathleen A Burke; Tari A King; Salvatore Piscuoglio; Audrey Mauguen; Irene Orlow; Britta Weigelt; Venkatraman E Seshan; Monica Morrow; Jorge S Reis-Filho
Journal:  Int J Cancer       Date:  2017-09-28       Impact factor: 7.396

4.  Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis.

Authors:  German Melean; Alba Marina Hernández; María Carmen Valero; Elisabete Hernández-Imaz; Yolanda Martín; Concepción Hernández-Chico
Journal:  BMC Cancer       Date:  2010-08-05       Impact factor: 4.430

5.  Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas.

Authors:  Pamela S Larson; Antonio de las Morenas; Sheila R Bennett; L Adrienne Cupples; Carol L Rosenberg
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

6.  Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.

Authors:  Anthony T Papenfuss; Mark Shackleton; Ismael A Vergara; Christopher P Mintoff; Shahneen Sandhu; Lachlan McIntosh; Richard J Young; Stephen Q Wong; Andrew Colebatch; Daniel L Cameron; Julia Lai Kwon; Rory Wolfe; Angela Peng; Jason Ellul; Xuelin Dou; Clare Fedele; Samantha Boyle; Gisela Mir Arnau; Jeanette Raleigh; Athena Hatzimihalis; Pacman Szeto; Jennifer Mooi; Daniel S Widmer; Phil F Cheng; Valerie Amann; Reinhard Dummer; Nicholas Hayward; James Wilmott; Richard A Scolyer; Raymond J Cho; David Bowtell; Heather Thorne; Kathryn Alsop; Stephen Cordner; Noel Woodford; Jodie Leditschke; Patricia O'Brien; Sarah-Jane Dawson; Grant A McArthur; Graham J Mann; Mitchell P Levesque
Journal:  Nat Commun       Date:  2021-03-04       Impact factor: 14.919

7.  Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.

Authors:  Sara Alkner; Man-Hung Eric Tang; Christian Brueffer; Malin Dahlgren; Yilun Chen; Eleonor Olsson; Christof Winter; Sara Baker; Anna Ehinger; Lisa Rydén; Lao H Saal; Mårten Fernö; Sofia K Gruvberger-Saal
Journal:  Breast Cancer Res       Date:  2015-08-05       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.